APA (7th ed.) Citation

Blumenfeld, A. M., Mechtler, L., Cook, L., Rhyne, C., Jenkins, B., Hughes, O., . . . Diamond, M. (2025). Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review. Pain & Therapy, 14(1), 441. https://doi.org/10.1007/s40122-024-00692-5

Chicago Style (17th ed.) Citation

Blumenfeld, Andrew M., Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, and Merle Diamond. "Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review." Pain & Therapy 14, no. 1 (2025): 441. https://doi.org/10.1007/s40122-024-00692-5.

MLA (9th ed.) Citation

Blumenfeld, Andrew M., et al. "Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review." Pain & Therapy, vol. 14, no. 1, 2025, p. 441, https://doi.org/10.1007/s40122-024-00692-5.